
SA gets R520m to buy twice-a-year anti-HIV jab — but there’s a snag
South Africa has accepted an offer of just over $29-million (about R520-million) from the Global Fund to Fight Aids, TB and Malaria to buy the twice-a-year anti-HIV jab, lenacapavir, that research shows could help to end Aids in the country, says Health …